Forge Biologics to Present at 2021 BIO Digital Conference

COLUMBUS, Ohio--(BUSINESS WIRE)--#genetherapy--Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that it will be delivering a company presentation at BIO Digital, hosted by the Biotechnology Innovation Organization, being held June 10-11 and 14-18, 2021. The presentation features CEO, President and Co-Founder Timothy J. Miller, Ph.D., Chief Medical Officer Maria Escolar, M.D., and Chief Technical Officer David Dismuke, Ph.D.

Event: 2021 BIO Digital, the annual BIO International Convention
Date: June 10-11 and 14-18, 2021
Time: The company presentations will be available on demand during and after the conference for attendees via the link below.
Event Hub session link:
https://biointernationalconvention21.hubb.me/fe/schedule-builder/sessions/795313
(Presentations will be available starting June 10)

Forge will be taking meetings during BIO Digital. Please contact Laura Carfagna at lcarfagna@forgebiologics.com if you are interested in connecting and learning more about how Forge’s manufacturing solutions can take your gene therapy from concept to reality.

About Forge Biologics

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea into reality. Forge has a 175,000 ft2 facility in Columbus, Ohio, “The Hearth,” to serve as its headquarters. The Hearth is the home of a custom-designed cGMP facility dedicated to AAV viral vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most.

For more information, please visit www.forgebiologics.com.

Media Inquiries
Dan Salvo
Director of Communications and Community Development
Forge Biologics Inc.
media@forgebiologics.com

Business Development
Magdalena Tyrpien
Vice President and Head of Business Development
Forge Biologics Inc.
BD@forgebiologics.com

Investor Relations
Christina Perry
Vice President, Finance and Operations
Forge Biologics Inc.
Investors@forgebiologics.com

Patient, Pediatrician, Genetic Counselors & Family Inquiries
Dr. Maria Escolar
Chief Medical Officer
Forge Biologics Inc.
medicalaffairs@forgebiologics.com